Novel immunosuppressive agent caerulomycin A exerts its effect by depleting cellular iron content.

Br J Pharmacol 2015 May 10;172(9):2286-99. Epub 2015 Feb 10.

Department of Chemistry, CSIR-Institute of Microbial Technology, Chandigarh, India.

Background And Purpose: Recently, we have described the use of caerulomycin A (CaeA) as a potent novel immunosuppressive agent. Immunosuppressive drugs are crucial for long-term graft survival following organ transplantation and treatment of autoimmune diseases, inflammatory disorders, hypersensitivity to allergens, etc. The objective of this study was to identify cellular targets of CaeA and decipher its mechanism of action.

Experimental Approach: Jurkat cells were treated with CaeA and cellular iron content, iron uptake/release, DNA content and deoxyribonucleoside triphosphate pool determined. Activation of MAPKs; expression level of transferrin receptor 1, ferritin and cell cycle control molecules; reactive oxygen species (ROS) and cell viability were measured using Western blotting, qRT-PCR or flow cytometry.

Key Results: CaeA caused intracellular iron depletion by reducing its uptake and increasing its release by cells. CaeA caused cell cycle arrest by (i) inhibiting ribonucleotide reductase (RNR) enzyme, which catalyses the rate-limiting step in the synthesis of DNA; (ii) stimulating MAPKs signalling transduction pathways that play an important role in cell growth, proliferation and differentiation; and (iii) by targeting cell cycle control molecules such as cyclin D1, cyclin-dependent kinase 4 and p21(CIP1/WAF1) . The effect of CaeA on cell proliferation was reversible.

Conclusions And Implications: CaeA exerts its immunosuppressive effect by targeting iron. The effect is reversible, which makes CaeA an attractive candidate for development as a potent immunosuppressive drug, but also indicates that iron chelation can be used as a rationale approach to selectively suppress the immune system, because compared with normal cells, rapidly proliferating cells require a higher utilization of iron.

Download full-text PDF

Source
http://dx.doi.org/10.1111/bph.13051DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403094PMC
May 2015
2 Reads

Publication Analysis

Top Keywords

cell cycle
12
cycle control
8
control molecules
8
iron content
8
caea
8
cellular iron
8
caea caused
8
novel immunosuppressive
8
immunosuppressive agent
8
iron
7
cell
6
ribonucleotide reductase
4
inhibiting ribonucleotide
4
reductase rnr
4
arrest inhibiting
4
caused cell
4
release cells
4
cells caea
4
rnr enzyme
4
increasing release
4

References

(Supplied by CrossRef)
T cell tolerance and autoimmunity
Abbas et al.
Autoimmun Rev 2004
Chemistry and biology of eukaryotic iron metabolism
Aisen et al.
Int J Biochem Cell Biol 2001
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander et al.
Br J Pharmacol 2013
Changes of deoxyribonucleoside triphosphate pools induced by hydroxyurea and their relation to DNA synthesis
Bianchi et al.
J Biol Chem 1986
The regulation of cellular iron metabolism
Chua et al.
Crit Rev Clin Lab Sci 2007
MAP kinase signalling pathways in cancer
Dhillon et al.
Oncogene 2007

Similar Publications